Abstract
All women in England with early stage breast cancer are to be tested to see if they could benefit from trastuzumab (Herceptin), and approval for use of the drug by...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
